Cargando…

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection

BACKGROUND: Periodontal disease and systemic health are closely associated. However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection. OBJECTIVES: The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagao, Yumiko, Kawahigashi, Yuji, Sata, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329233/
https://www.ncbi.nlm.nih.gov/pubmed/25737729
http://dx.doi.org/10.5812/hepatmon.23264
_version_ 1782357407876251648
author Nagao, Yumiko
Kawahigashi, Yuji
Sata, Michio
author_facet Nagao, Yumiko
Kawahigashi, Yuji
Sata, Michio
author_sort Nagao, Yumiko
collection PubMed
description BACKGROUND: Periodontal disease and systemic health are closely associated. However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection. OBJECTIVES: The aim of this study was to evaluate the association between periodontitis and progression of liver diseases in patients with HCV and/or HBV infection. PATIENTS AND METHODS: In this retrospective study, 351 patients with HCV- and/or HBV-related liver diseases underwent screening for periodontal disease using the Salivaster® salivary occult blood test from February 2010 to June 2014. Furthermore, we examined the prevalence of fimbrillin (fimA) genotype of Porphyromonas gingivalis (P. gingivalis) in 28 HCV-infected patients visited at our hospital between January 2013 and June 2014. P. gingivalis with fimA genotype with types I to V was further detected using a PCR method. RESULTS: Of 351 patients, 76 patients (group 1) had a strong positive result for salivary occult blood test and 275 patients (group 2) had weak positive or negative test results. Significant factors between the groups were obesity, level of AST, ALT, LDH, ALP, Alb, D.Bil, T.cho, AFP, platelets (Plt), IRI, HOMA-IR, current interferon (IFN) treatment and the daily frequency of tooth brushing. Between-groups analysis indicated that total protein (T.pro) level and liver fibrosis were significant factors. According to multivariate analysis, five factors were associated with periodontal disease as Plt count below 80000, brushing teeth only once a day, current IFN treatment, aged 65 years or older and obesity. The adjusted odds ratios for these five factors were 5.80, 3.46, 2.87, 2.50 and 2.33, respectively, and each was statistically significant. Twenty-eight saliva specimens had positive results for P. gingivalis with fimA genotype types I to V. The prevalence of fimA genotype II was higher in 14 patients with liver cirrhosis or a history of hepatocellular carcinoma treatment (group B, 50.00%) than 14 patients with only hepatitis C (group A, 21.43%). CONCLUSIONS: Periodontitis might be associated with progression of viral liver disease; hence, controlling oral disease is essential for the prevention and management of liver fibrosis.
format Online
Article
Text
id pubmed-4329233
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-43292332015-03-03 Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection Nagao, Yumiko Kawahigashi, Yuji Sata, Michio Hepat Mon Research Article BACKGROUND: Periodontal disease and systemic health are closely associated. However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection. OBJECTIVES: The aim of this study was to evaluate the association between periodontitis and progression of liver diseases in patients with HCV and/or HBV infection. PATIENTS AND METHODS: In this retrospective study, 351 patients with HCV- and/or HBV-related liver diseases underwent screening for periodontal disease using the Salivaster® salivary occult blood test from February 2010 to June 2014. Furthermore, we examined the prevalence of fimbrillin (fimA) genotype of Porphyromonas gingivalis (P. gingivalis) in 28 HCV-infected patients visited at our hospital between January 2013 and June 2014. P. gingivalis with fimA genotype with types I to V was further detected using a PCR method. RESULTS: Of 351 patients, 76 patients (group 1) had a strong positive result for salivary occult blood test and 275 patients (group 2) had weak positive or negative test results. Significant factors between the groups were obesity, level of AST, ALT, LDH, ALP, Alb, D.Bil, T.cho, AFP, platelets (Plt), IRI, HOMA-IR, current interferon (IFN) treatment and the daily frequency of tooth brushing. Between-groups analysis indicated that total protein (T.pro) level and liver fibrosis were significant factors. According to multivariate analysis, five factors were associated with periodontal disease as Plt count below 80000, brushing teeth only once a day, current IFN treatment, aged 65 years or older and obesity. The adjusted odds ratios for these five factors were 5.80, 3.46, 2.87, 2.50 and 2.33, respectively, and each was statistically significant. Twenty-eight saliva specimens had positive results for P. gingivalis with fimA genotype types I to V. The prevalence of fimA genotype II was higher in 14 patients with liver cirrhosis or a history of hepatocellular carcinoma treatment (group B, 50.00%) than 14 patients with only hepatitis C (group A, 21.43%). CONCLUSIONS: Periodontitis might be associated with progression of viral liver disease; hence, controlling oral disease is essential for the prevention and management of liver fibrosis. Kowsar 2014-12-20 /pmc/articles/PMC4329233/ /pubmed/25737729 http://dx.doi.org/10.5812/hepatmon.23264 Text en Copyright © 2014, Kowsar Corp. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Nagao, Yumiko
Kawahigashi, Yuji
Sata, Michio
Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
title Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
title_full Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
title_fullStr Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
title_full_unstemmed Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
title_short Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
title_sort association of periodontal diseases and liver fibrosis in patients with hcv and/or hbv infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329233/
https://www.ncbi.nlm.nih.gov/pubmed/25737729
http://dx.doi.org/10.5812/hepatmon.23264
work_keys_str_mv AT nagaoyumiko associationofperiodontaldiseasesandliverfibrosisinpatientswithhcvandorhbvinfection
AT kawahigashiyuji associationofperiodontaldiseasesandliverfibrosisinpatientswithhcvandorhbvinfection
AT satamichio associationofperiodontaldiseasesandliverfibrosisinpatientswithhcvandorhbvinfection